Narsis Attar

3.4k total citations · 1 hit paper
13 papers, 2.6k citations indexed

About

Narsis Attar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Narsis Attar has authored 13 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Immunology. Recurrent topics in Narsis Attar's work include Melanoma and MAPK Pathways (5 papers), Mitochondrial Function and Pathology (2 papers) and Epigenetics and DNA Methylation (2 papers). Narsis Attar is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Mitochondrial Function and Pathology (2 papers) and Epigenetics and DNA Methylation (2 papers). Narsis Attar collaborates with scholars based in United States, Australia and Spain. Narsis Attar's co-authors include Antoni Ribas, Richard C. Koya, Roger S. Lo, Ramin Nazarian, Thinle Chodon, Hooman Sazegar, Qi Wang, Hubing Shi, Mi‐Kyung Lee and Stanley F. Nelson and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Narsis Attar

13 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

2010 1.6k citations Ramin Nazarian, Hubing Shi et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Narsis Attar United States	11	2.1k	1.3k	359	298	297	13	2.6k
Hooman Sazegar United States	7	1.7k 0.8×	1.2k 0.9×	328 0.9×	258 0.9×	326 1.1×	7	2.1k
Maria Karasarides United States	12	1.8k 0.9×	833 0.6×	237 0.7×	262 0.9×	260 0.9×	20	2.3k
Paul Wan United Kingdom	9	1.9k 0.9×	991 0.7×	326 0.9×	425 1.4×	130 0.4×	9	2.5k
Kim H.T. Paraiso United States	23	1.9k 0.9×	954 0.7×	251 0.7×	203 0.7×	589 2.0×	28	2.5k
Chris M. Jones United Kingdom	3	1.7k 0.8×	962 0.7×	315 0.9×	421 1.4×	110 0.4×	4	2.2k
Robert Hayward United Kingdom	16	1.7k 0.8×	812 0.6×	218 0.6×	178 0.6×	274 0.9×	21	2.1k
Steven R. Whittaker United Kingdom	20	2.3k 1.1×	1.4k 1.1×	416 1.2×	515 1.7×	177 0.6×	28	3.2k
Inna V. Fedorenko United States	16	1.3k 0.6×	809 0.6×	238 0.7×	190 0.6×	195 0.7×	27	1.6k
Ensar Halilovic United States	19	1.8k 0.8×	977 0.7×	179 0.5×	336 1.1×	128 0.4×	33	2.3k
Alastair J. King United States	18	1.6k 0.8×	659 0.5×	195 0.5×	182 0.6×	223 0.8×	28	2.0k

Countries citing papers authored by Narsis Attar

Since Specialization

Citations

This map shows the geographic impact of Narsis Attar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narsis Attar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narsis Attar more than expected).

Fields of papers citing papers by Narsis Attar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narsis Attar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narsis Attar. The network helps show where Narsis Attar may publish in the future.

Co-authorship network of co-authors of Narsis Attar

This figure shows the co-authorship network connecting the top 25 collaborators of Narsis Attar. A scholar is included among the top collaborators of Narsis Attar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narsis Attar. Narsis Attar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Attar, Narsis, Diana Cirstea, Andrew R. Branagan, et al.. (2023). Use of Cilta-Cel CAR T Cells Following Previous Use of a BCMA-Directed CAR T-Cell Product in Heavily Treated Patients with Relapsed/Refractory Multiple Myeloma: A Single Institution Case Series. Blood. 142(Supplement 1). 6924–6924. 1 indexed citations

Attar, Narsis, Chen Cheng, Maria Vogelauer, et al.. (2021). A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s ataxia. Science Advances. 7(51). eabj9889–eabj9889. 13 indexed citations

Attar, Narsis & Elizabeth O’Donnell. (2021). Induction Therapy Strategies in the Transplant-Ineligible Population. The Cancer Journal. 27(3). 196–200. 1 indexed citations

Attar, Narsis, Maria Vogelauer, Chen Cheng, et al.. (2020). The histone H3-H4 tetramer is a copper reductase enzyme. Science. 369(6499). 59–64. 72 indexed citations

Xue, Yong, Stefan Schmollinger, Narsis Attar, et al.. (2017). Endoplasmic reticulum–mitochondria junction is required for iron homeostasis. Journal of Biological Chemistry. 292(32). 13197–13204. 46 indexed citations

Attar, Narsis & Siavash K. Kurdistani. (2016). Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. Cold Spring Harbor Perspectives in Medicine. 7(3). a026534–a026534. 162 indexed citations

Nguyen, Andrew H., Irmina A. Elliott, Nanping Wu, et al.. (2016). Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Oncotarget. 8(12). 19074–19088. 24 indexed citations

Euw, Erika von, Mohammad Atefi, Narsis Attar, et al.. (2012). Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Molecular Cancer. 11(1). 22–22. 61 indexed citations

Niehr, Franziska, Erika von Euw, Narsis Attar, et al.. (2011). Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations. Journal of Translational Medicine. 9(1). 76–76. 78 indexed citations

10.

Atefi, Mohammad, Erika von Euw, Narsis Attar, et al.. (2011). Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway. PLoS ONE. 6(12). e28973–e28973. 183 indexed citations

11.

Nazarian, Ramin, Hubing Shi, Qi Wang, et al.. (2010). Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 468(7326). 973–977. 1614 indexed citations breakdown →

12.

Søndergaard, Jonas Nørskov, Ramin Nazarian, Qi Wang, et al.. (2010). Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032. Journal of Translational Medicine. 8(1). 171 indexed citations

13.

Euw, Erika von, Thinle Chodon, Narsis Attar, et al.. (2009). CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. Journal of Translational Medicine. 7(1). 35–35. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact